These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 21458446

  • 1. Reversal effects of two new milbemycin compounds on multidrug resistance in MCF-7/adr cells in vitro.
    Gao A, Liang H, Wang X, Zhang X, Jing M, Zhang J, Yan Y, Xiang W.
    Eur J Pharmacol; 2011 Jun 01; 659(2-3):108-13. PubMed ID: 21458446
    [Abstract] [Full Text] [Related]

  • 2. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W, Gao A, Liang H, Li C, Gao J, Wang Q, Shuang B, Zhang J, Yan Y, Wang X.
    Toxicol In Vitro; 2010 Sep 01; 24(6):1474-81. PubMed ID: 20656007
    [Abstract] [Full Text] [Related]

  • 3. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX, Yang XH.
    Yao Xue Xue Bao; 2008 May 01; 43(5):461-6. PubMed ID: 18717331
    [Abstract] [Full Text] [Related]

  • 4. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.
    J Pharm Pharmacol; 2004 Aug 01; 56(8):1061-6. PubMed ID: 15285852
    [Abstract] [Full Text] [Related]

  • 5. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
    Gao A, Wang X, Xiang W, Liang H, Gao J, Yan Y.
    J Pharm Pharmacol; 2010 Mar 01; 62(3):393-9. PubMed ID: 20487225
    [Abstract] [Full Text] [Related]

  • 6. A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells.
    Shi R, Li W, Zhang X, Zhang Y, Peng H, Xie Y, Fan D, Liu R, Liu X, Xiong D.
    Eur J Pharmacol; 2011 Nov 01; 669(1-3):38-44. PubMed ID: 21871878
    [Abstract] [Full Text] [Related]

  • 7. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
    Sun LR, Li X, Cheng YN, Yuan HY, Chen MH, Tang W, Ward SG, Qu XJ.
    Biomed Pharmacother; 2009 Mar 01; 63(3):202-8. PubMed ID: 18818047
    [Abstract] [Full Text] [Related]

  • 8. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C, Guan X, Xue H, Wang P, Wang M, Gai X.
    Pathol Res Pract; 2017 Jul 01; 213(7):848-853. PubMed ID: 28554760
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R, Peng H, Yuan X, Zhang X, Zhang Y, Fan D, Liu X, Xiong D.
    J Cell Biochem; 2013 Aug 01; 114(8):1890-900. PubMed ID: 23494858
    [Abstract] [Full Text] [Related]

  • 10. Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells.
    Yu ST, Chen TM, Tseng SY, Chen YH.
    Biochem Biophys Res Commun; 2007 Jun 22; 358(1):79-84. PubMed ID: 17482571
    [Abstract] [Full Text] [Related]

  • 11. Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic.
    Ma B, Chai S, Li N, To KK, Kan WL, Yang D, Lin G.
    Int J Pharm; 2012 Mar 15; 424(1-2):33-9. PubMed ID: 22226881
    [Abstract] [Full Text] [Related]

  • 12. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.
    Li F, Fan J, Wu Z, Liu RY, Guo L, Dong Z, Wang Z.
    Pharm Biol; 2013 Sep 15; 51(9):1196-203. PubMed ID: 23777360
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
    Xu D, Lu Q, Hu X.
    Cancer Lett; 2006 Nov 18; 243(2):274-80. PubMed ID: 16406853
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.
    Ji BS, He L.
    J Pharm Pharmacol; 2007 Jul 18; 59(7):1011-5. PubMed ID: 17637197
    [Abstract] [Full Text] [Related]

  • 17. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W, Li Y, Cai Y, Kang K, Yan F, Liu G, Huang W.
    J Pharm Pharmacol; 2007 Dec 18; 59(12):1649-55. PubMed ID: 18053326
    [Abstract] [Full Text] [Related]

  • 18. Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells.
    Tran TP, Kim HG, Choi JH, Na MK, Jeong HG.
    Phytomedicine; 2013 May 15; 20(7):622-31. PubMed ID: 23466342
    [Abstract] [Full Text] [Related]

  • 19. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X, Sun B, Zhu CJ, Yuan HQ, Shi YQ, Gao J, Li SJ, Lou HX.
    Toxicol In Vitro; 2009 Feb 15; 23(1):29-36. PubMed ID: 18938236
    [Abstract] [Full Text] [Related]

  • 20. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.